This Phase III trial tests whether a de-escalated (less intense) version of the standard MATRix chemotherapy regimen works as well for newly diagnosed primary CNS lymphoma. About 331 patients will receive either the standard four courses of MATRix or a reduced schedule with one c…
Phase: PHASE3 • Sponsor: Klinikum Stuttgart • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC